COI code: SRCCG05_046
Paper Language: English
How to Download This Paper
For Downloading the Fulltext of CIVILICA papers please visit the orginal Persian Section of website.
Authors Mesenchymal stem cells-derived extracellular vesicles as a new therapeutic option in regenerative medicineAli shahabaddini parizi - Department of Laboratory of Sciences, Faculty of Paramedical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Aliakbar Yousefi-Ahmadipour - Department of Laboratory of Sciences, Faculty of Paramedical Sciences, Rafsanjan University of Medical Sciences, Rafsanjan, Iran
Somayeh Ebrahimi-Barough - Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran
Abstract:Mesenchymal stromal cells MSCs are multi-potent stem cells with differentiate potential to more tissues such as fat, bone, and cartilage . They have the ability to implant at the site of damaged tissue and to repair these areas by proliferation and dividing into specific cells. For this reason, they are of particular importance in regenerative medicine. It is believed that this healing feature is mediated by secreting survival factors and releasing extracellular vesicles EVs such as exosomes. The EVs are important mediators of intercellular communication and regulators of the cellular niche, and also they are important both for diagnostic and therapeutic purposes using EVs as drug delivery vehicles . In addition, the EVs are able to cross biological barriers without rejection can shuttle bioactive molecules from one cell to another, causing the exchange of genetic information and reprogramming of the recipient cells. This review is an overview of EVs released from the MSCs that have been promising approach for use in cell-free therapies rather than using native and engineered stem cells, because EVs do not have the risks and limitations of cellbased therapies.
Keywords:Mesenchymal Stem Cells, Extracellular vesicles, Exosome, Regenerative medicine.
COI code: SRCCG05_046
how to cite to this paper:If you want to refer to this article in your research, you can easily use the following in the resources and references section:
shahabaddini parizi, Ali; Aliakbar Yousefi-Ahmadipour & Somayeh Ebrahimi-Barough, 2019, Mesenchymal stem cells-derived extracellular vesicles as a new therapeutic option in regenerative medicine, 5th congress of student research committee of rafsanjan university of medical sciences, رفسنجان, دانشگاه علوم پزشكي رفسنجان, https://www.civilica.com/Paper-SRCCG05-SRCCG05_046.htmlInside the text, wherever referred to or an achievement of this article is mentioned, after mentioning the article, inside the parental, the following specifications are written.
First Time: (shahabaddini parizi, Ali; Aliakbar Yousefi-Ahmadipour & Somayeh Ebrahimi-Barough, 2019)
Second and more: (shahabaddini parizi; Yousefi-Ahmadipour & Ebrahimi-Barough, 2019)
For a complete overview of how to citation please review the following CIVILICA Guide (Citation)
The University/Research Center Information:
Type: Medical University
Paper No.: 288
in University Ranking and Scientometrics the Iranian universities and research centers are evaluated based on scientific papers.
Research Info Management
Export Citation info of this paper to research management softwares
Iran Scientific Advertisment Netword
Share this paper
WHAT IS COI?
COI is a national code dedicated to all Iranian Conference and Journal Papers. the COI of each paper can be verified online.